Home › Pulmonary Arterial Hypertension › Missouri › St. Louis
Pulmonary Arterial Hypertension clinical trials in St. Louis, MO
3 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- Washington University School of Medicine, St Louis
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RecruitingPhase 3
- Washington University School of Medicine, St Louis
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Washington University in St. Louis, St Louis
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Houston, TX4 studies
- Louisville, KY4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.